Arizona State Retirement System’s CytomX Therapeutics CTMX Stock Holding History

Arizona State Retirement System’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168K	Buy	44,737 +360	+0.8%	+$1.38K	﹤0.01%	2002
2026 Q1	$209K	Buy	+44,377	New	+$225K	﹤0.01%	1878
2021 Q4	–	Sell	-14,167	Closed	-$72K	–	2275
2021 Q3	$72K	Buy	14,167 +79	+0.6%	+$423	﹤0.01%	2191
2021 Q2	$89K	Sell	14,088 -884	-6%	-$6.88K	﹤0.01%	2211
2021 Q1	$116K	Buy	14,972 +2,974	+25%	+$23.5K	﹤0.01%	2111
2020 Q4	$79K	Sell	11,998 -473	-4%	-$3.38K	﹤0.01%	2083
2020 Q3	$83K	Buy	+12,471	New	+$92.5K	﹤0.01%	1967
2020 Q2	–	Sell	-10,666	Closed	-$82K	–	1870
2020 Q1	$82K	Buy	+10,666	New	+$74.4K	﹤0.01%	1691

Other funds holding CTMX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Arizona State Retirement System's CTMX Position: Q2 2026 in Review

Arizona State Retirement System increased its CytomX Therapeutics (CTMX) stake by 0.81% in Q2 2026, buying an estimated $1.38K and bringing the position to 44,737 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

Arizona State Retirement System first reported a position in CTMX in Q1 2020 and has held it in 8 quarters since. The position peaked at $209K in Q1 2026. 179 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

Arizona State Retirement System held 44,737 shares of CytomX Therapeutics worth $168K as of Q2 2026.
Arizona State Retirement System bought 360 CytomX Therapeutics shares in Q2 2026, an estimated $1.38K.
CytomX Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #2002 holding.
Arizona State Retirement System first reported a position in CytomX Therapeutics in Q1 2020 and has held it in 8 quarters since.
Arizona State Retirement System's CytomX Therapeutics position peaked at $209K in Q1 2026.
179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.